During the past decade, Japanese Red Cross Hamamatsu Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Japanese Red Cross Hamamatsu Hospital" are "Chronic Pain" (1 trials), "Low Back Pain" (1 trials), "Osteoarthritis, Hip" (1 trials) and "Osteoarthritis, Knee" (1 trials). Many other conditions were trialed in "Japanese Red Cross Hamamatsu Hospital" in a lesser frequency.

Most popular intervention types in "Japanese Red Cross Hamamatsu Hospital" are "Biological" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Tanezumab 5 mg" (2 trials), "Celecoxib" (1 trials), "NSAID" (1 trials), "Placebo for celecoxib" (1 trials) and "Placebo for tanezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Japanese Red Cross Hamamatsu Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Japanese Red Cross Hamamatsu Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Japanese Red Cross Hamamatsu Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Japanese Red Cross Hamamatsu Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".